Clinical Research Directory
Browse clinical research sites, groups, and studies.
A Clinical Study of KLH-2109 in Patients With Endometriosis
Sponsor: Kissei Pharmaceutical Co., Ltd.
Summary
To verify the non-inferiority of KLH-2109 to leuprorelin acetate in a double-blind manner in terms of efficacy in endometriosis patients with pelvic pain.
Official title: Phase III Confirmatory Study of KLH-2109 in Patients With Endometriosis
Key Details
Gender
FEMALE
Age Range
18 Years - Any
Study Type
INTERVENTIONAL
Enrollment
288
Start Date
2025-06-09
Completion Date
2027-11
Last Updated
2026-03-02
Healthy Volunteers
No
Conditions
Interventions
KLH-2109
\- KLH-2109 tablet: Oral administration \- Leuprorelin acetate placebo: Subcutaneous administration
Leuprorelin acetate
\- KLH-2109 placebo tablet: Oral administration \- Leuprorelin acetate: Subcutaneous administration
Locations (1)
Research Site
Multiple Locations, Japan